Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prelude Therapeutics Inc

0.7987
-0.0113-1.40%
Post-market: 0.7703-0.0284-3.56%17:21 EDT
Volume:76.85K
Turnover:62.08K
Market Cap:44.05M
PE:-0.48
High:0.8499
Open:0.7939
Low:0.7800
Close:0.8100
Loading ...
May 04, 2024

Correspondence

Form CORRESP - Correspondence
May 02, 2024

Correspondence

Form CORRESP - Correspondence
Apr 10, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 20, 2023

Major Issues Report

Form 8-K - Current report